Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | SVP, Chief Marketing Officer | May 22, 2026 | May 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date May 22, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 41,480 |
Reported balance
After 2026-05-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-22 · Sale · Disposed 11,876 · Balance 41,480 F1: The shares were sold in multiple transactions at prices ranging from $54.315 to $55.08 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2: Shares held following the reported transaction includes 41,480 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold in multiple transactions at prices ranging from $54.315 to $55.08 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Shares held following the reported transaction includes 41,480 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,813 | $68.40 | $397,609.20 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 9 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,500 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · derivative · entry 14 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 13,500 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This performance-based stock option award was granted for a total of 18,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 13,500 shares. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,113 | $0.00 Strike: $68.40 | $0.00 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · derivative · entry 13 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,548 Underlying: Class A Common Stock · 2,113 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,437 | $0.00 Strike: $62.43 | $0.00 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · derivative · entry 12 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,209 Underlying: Class A Common Stock · 23,437 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,750 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · derivative · entry 11 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 6,750 shares Expires 2028-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 13,500 | $75.02 | $1,012,791.60 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 8 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,788 F5 · price: The shares were sold in multiple transactions at prices ranging from $75.00 to $75.12, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 13,500 | $64.60 | $872,100.00 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 7 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,113 | $75.14 | $158,771.67 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 6 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,788 F4 · price: The shares were sold in multiple transactions at prices ranging from $75.13 to $75.15, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,113 | $68.40 | $144,529.20 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 5 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 23,437 | $75.47 | $1,768,755.23 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,788 F3 · price: The shares were sold in multiple transactions at prices ranging from $75.155 to $75.76, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 23,437 | $62.43 | $1,463,171.91 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,750 | $75.94 | $512,575.43 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,788 F2 · price: The shares were sold in multiple transactions at prices ranging from $75.77 to $76.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 6,750 | $64.60 | $436,050.00 |
DisclosureSEC source: 0001209191-22-031016 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 01:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,116 | $92.00 | $102,672.00 |
DisclosureSEC source: 0001209191-21-070705 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,788 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 33,878 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,153 | $91.80 | $105,845.40 |
DisclosureSEC source: 0001209191-21-070103 · doc4.xml · nonDerivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,904 F5 · balance_after: Shares held following the reported transactions include 36,128 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 27,020 | $0.00 Strike: $91.80 | $0.00 |
DisclosureSEC source: 0001209191-21-070103 · doc4.xml · derivative · entry 5 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,020 Underlying: Class A Common Stock · 27,020 shares Expires 2031-12-15 F7 · derivative.exercise_date: This option was granted for a total of 27,020 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2021, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 6,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070103 · doc4.xml · derivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,527 Underlying: Class A Common Stock · 6,527 shares Expires not disclosed F6 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 13,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070103 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,057 F3 · acquired: Award represents a total of 13,054 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2021. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F4 · balance_after: Shares held following the reported transactions include 38,453 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,578 | $90.55 | $142,887.90 |
DisclosureSEC source: 0001209191-21-070103 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,003 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 25,399 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 881 | $0.00 Strike: $68.40 | $0.00 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · derivative · entry 9 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,661 Underlying: Class A Common Stock · 881 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,604 | $0.00 Strike: $62.43 | $0.00 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · derivative · entry 8 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,646 Underlying: Class A Common Stock · 2,604 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · derivative · entry 7 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Class A Common Stock · 750 shares Expires 2028-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 881 | $98.62 | $86,884.22 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · nonDerivative · entry 6 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 881 | $68.40 | $60,260.40 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · nonDerivative · entry 5 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,604 | $98.62 | $256,806.48 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · nonDerivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,604 | $62.43 | $162,567.72 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · nonDerivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 750 | $98.62 | $73,965.00 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 00:54 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 750 | $64.60 | $48,450.00 |
DisclosureSEC source: 0001209191-21-054179 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,404 | $0.00 Strike: $68.40 | $0.00 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · derivative · entry 9 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,542 Underlying: Class A Common Stock · 4,404 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,653 | $0.00 Strike: $62.43 | $0.00 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · derivative · entry 8 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Class A Common Stock · 5,653 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,750 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · derivative · entry 7 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,750 Underlying: Class A Common Stock · 3,750 shares Expires 2028-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,404 | $98.19 | $432,442.85 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · nonDerivative · entry 6 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 F4 · price: The shares were sold in multiple transactions at prices ranging from $98.145 to $98.28, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 4,404 | $68.40 | $301,233.60 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · nonDerivative · entry 5 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 5,653 | $98.63 | $557,578.00 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · nonDerivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 F3 · price: The shares were sold in multiple transactions at prices ranging from $98.28 to $99.10, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,653 | $62.43 | $352,916.79 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · nonDerivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 3,750 | $98.10 | $367,861.13 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 F2 · price: The shares were sold in multiple transactions at prices ranging from $98.03 to $98.145, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 22:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 3,750 | $64.60 | $242,250.00 |
DisclosureSEC source: 0001209191-21-050669 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 22:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,368 | $0.00 Strike: $62.43 | $0.00 |
DisclosureSEC source: 0001209191-21-050042 · doc4.xml · derivative · entry 4 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,903 Underlying: Class A Common Stock · 7,368 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 22:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,368 | $100.01 | $736,884.00 |
DisclosureSEC source: 0001209191-21-050042 · doc4.xml · nonDerivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 F3 · price: The shares were sold in multiple transactions at prices ranging from $100.00 to $100.155, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 22:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,368 | $62.43 | $459,984.24 |
DisclosureSEC source: 0001209191-21-050042 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 22:18 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,746 | $100.10 | $274,878.17 |
DisclosureSEC source: 0001209191-21-050042 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 F1 · price: The shares were sold in multiple transactions at prices ranging from $100.115 to $100.22, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| July 16, 2021 Filed Jul 16, 2021 20:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,629 | $99.82 | $162,606.78 |
DisclosureSEC source: 0001209191-21-046941 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,327 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 21:20 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,229 | $0.00 Strike: $68.40 | $0.00 |
DisclosureSEC source: 0001209191-21-013776 · doc4.xml · derivative · entry 3 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,946 Underlying: Class A Common Stock · 10,229 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 21:20 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 10,229 | $95.09 | $972,645.95 |
DisclosureSEC source: 0001209191-21-013776 · doc4.xml · nonDerivative · entry 2 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,956 F2 · price: The shares were sold in multiple transactions at prices ranging from $95.05 to $95.30, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 21:20 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 10,229 | $68.40 | $699,663.60 |
DisclosureSEC source: 0001209191-21-013776 · doc4.xml · nonDerivative · entry 1 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,100 | $0.00 Strike: $68.40 | $0.00 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · derivative · entry 10 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,175 Underlying: Class A Common Stock · 2,100 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,813 | $0.00 Strike: $62.43 | $0.00 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · derivative · entry 9 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,271 Underlying: Class A Common Stock · 7,813 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · derivative · entry 8 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Class A Common Stock · 2,250 shares Expires 2028-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,306 | $94.13 | $217,054.79 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · nonDerivative · entry 7 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,956 F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 01:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,100 | $94.01 | $197,412.81 |
DisclosureSEC source: 0001209191-21-013012 · doc4.xml · nonDerivative · entry 6 Pendleton Todd · CIK 0001746636 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,262 F3 · price: The shares were sold in multiple transactions at prices ranging from $94.00 to $94.02, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.